Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND Failure to report the results of a clinical trial can distort the evidence base for clinical practice, breaches researchers' ethical obligations to participants, and represents an important source of research waste. The Food and Drug Administration Amendments Act (FDAAA) of 2007 now requires sponsors of applicable trials to report their results directly onto ClinicalTrials.gov within 1 year of completion. The first trials covered by the Final Rule of this act became due to report results in January, 2018. In this cohort study, we set out to assess compliance. METHODS We downloaded data for all registered trials on ClinicalTrials.gov each month from March, 2018, to September, 2019. All cross-sectional analyses in this manuscript were performed on data extracted from ClinicalTrials.gov on Sept 16, 2019; monthly trends analysis used archived data closest to the 15th day of each month from March, 2018, to September, 2019. Our study cohort included all applicable trials due to report results under FDAAA. We excluded all non-applicable trials, those not yet due to report, and those given a certificate allowing for delayed reporting. A trial was considered reported if results had been submitted and were either publicly available, or undergoing quality control review at ClinicalTrials.gov. A trial was considered compliant if these results were submitted within 1 year of the primary completion date, as required by the legislation. We described compliance with the FDAAA 2007…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [59]
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [59]
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [59]
In the citing paper
“The reporting of results of clinical trials is required, but trial sponsors are less adherent to this expectation.”
From Alzheimer’s disease drug development pipeline: 2021 (2021) · cites this paper as [17]
Citations
Cites
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
Dwan, K., Gamble, C., Williamson, P. R., Kirkham, J. J., & the Reporting Bias Group (2013) · PLoS ONE · doi:10.1371/journal.pone.0066844 · Cited by 1,127
Increasing value and reducing waste in biomedical research: who's listening?
Moher, D., Glasziou, P., Chalmers, I., Nasser, M., Bossuyt, P. M. M., Korevaar, D. A., Graham, I. D., Ravaud, P., & Boutron, I. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00307-4 · Cited by 462
Compliance with Results Reporting at ClinicalTrials.gov
Anderson, M. L., Chiswell, K., Peterson, E. D., Tasneem, A., Topping, J., & Califf, R. M. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1409364 · Cited by 380
Trial Reporting in ClinicalTrials.gov — The Final Rule
Zarin, D. A., Tse, T., Williams, R. J., & Carr, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1611785 · Cited by 332
Prayle, A. P., Hurley, M. N., & Smyth, A. R. (2012) · BMJ · doi:10.1136/bmj.d7373 · Cited by 290
Schmucker, C., Schell, L. K., Portalupi, S., Oeller, P., Cabrera, L., Bassler, D., Schwarzer, G., Scherer, R. W., Antes, G., von Elm, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114023 · Cited by 269
Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
Riveros, C., Dechartres, A., Perrodeau, E., Haneef, R., Boutron, I., & Ravaud, P. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001566 · Cited by 269
Hartung, D. M., Zarin, D. A., Guise, J.-M., McDonagh, M., Paynter, R., & Helfand, M. (2014) · Annals of Internal Medicine · doi:10.7326/m13-0480 · Cited by 239
Research works printed but not linked: 4
- 2012, Commission guideline — guidance on posting and publication of result-related information on clinical trials in relation to the implementation of Article 57(2) of Regulation (EC) No 726/2004 and Article 41(2) of Regulation (EC) No 1901/2006, Official J Eur Union, 55, 7
- Davidson-Pilon, 2019, CamDavidsonPilon/lifelines: v0.22.0 (version v0.22.0), Zenodo
- DeVito, 2020, ebmdatalab/fdaaa_trends: code to assess compliance with FDAAA 2007 (version v1.0), Zenodo
- 2019, Annual civil monetary penalties inflation adjustment. Final Rule, Fed Regist, 84, 59549
Cited by
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., & Koffel, J. (2019) · doi:10.31219/osf.io/sfc38 · Cited by 3,696
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., PRISMA-S Group, Blunt, H., Brigham, T., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01542-z · Cited by 3,714
Alzheimer’s disease drug development pipeline: 2021
Cummings, J., Lee, G., Zhong, K., Fonseca, J., & Taghva, K. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12179 · Cited by 539
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., & Group, P.-S. (2021) · Journal of the Medical Library Association · doi:10.5195/jmla.2021.962 · Cited by 409
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
BackgroundRace/ethnicity reporting and representation in US clinical trials: A cohort study
Turner, B. E., Steinberg, J. R., Weeks, B. T., Rodriguez, F., & Cullen, M. R. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100252 · Cited by 395
Metadata
- Authors
- DeVito, N. J., Bacon, S., & Goldacre, B.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Goldacre, Ben
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 395
- Issue
- 10221
- Pages
- 361-369
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2998808595
- Cited by
- 336
- References
- 27
- Citations by year
- 2026: 37 · 2025: 47 · 2024: 44 · 2023: 47 · 2022: 81 · 2021: 41 · 2020: 37
- FWCI
- 45.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Keywords
- regulatory compliance, clinical trial registration, research transparency, research waste, NCI, NIMBY
- MeSH terms
- Clinical Trials as Topic, Cooperative Behavior, Humans, Registries, United States, United States Food and Drug Administration, Cohort Studies, Disclosure, Biomedical Research, Research Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study. https://app.cochat.ai/papers/10.1016/s0140-6736(19)33220-9
- The paper
- DeVito, N. J., Bacon, S., & Goldacre, B. (2020). Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study. The Lancet. https://doi.org/10.1016/s0140-6736(19)33220-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.